Skip to main content
Top
Published in: World Journal of Surgery 12/2011

01-12-2011

Effect of Perioperative Intensive Insulin Therapy for Liver Dysfunction After Hepatic Resection

Authors: Takehiro Okabayashi, Kengo Ichikawa, Tsutomu Namikawa, Takeki Sugimoto, Michiya Kobayashi, Kazuhiro Hanazaki

Published in: World Journal of Surgery | Issue 12/2011

Login to get access

Abstract

Background

Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical care units, yet the benefits of IIT during liver surgery, especially on liver function after hepatic resection, are not known. The aim of the present study was to assess the effects of IIT, with a focus on postoperative liver function, in hepatectomized patients.

Methods

A total of 150 patients who underwent surgical management for hepatic diseases between September 2007 and March 2009 at Kochi Medical School were investigated. Patients were divided into two groups: (1) those receiving IIT via a closed-loop glycemic control system (i.e., an artificial pancreas; AP group; n = 74); or (2) those receiving conventional insulin therapy using the sliding scale method (SS group; n = 76). The targeted blood glucose zones in the AP and SS groups were 80–110 and 150–200 mg/dl, respectively.

Results

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels increased and prothrombin time (%) decreased immediately after surgery in both groups. There was a significant difference in postoperative ALT levels between the two groups on postoperative days 1 and 6. Hepatocyte injury and changes in AST and ALT levels after surgery (compared with preoperative levels) were significantly greater in the SS group than AP group after liver resection. During the first 18 h after hepatic resection, 174 IU of insulin was required per patient for tight glycemic control with IIT.

Conclusions

Perioperative IIT ameliorated liver dysfunction after hepatic resection. Liver regeneration and/or an antiinflammatory effect of IIT may underlie its protective effects against hepatocyte injury in hepatectomized patients.
Literature
1.
go back to reference Van den Berghe G, Wouters PJ, Bouillon R et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMedCrossRef Van den Berghe G, Wouters PJ, Bouillon R et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359–366PubMedCrossRef
2.
go back to reference Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef
3.
go back to reference Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRef Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMedCrossRef
4.
go back to reference Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults. JAMA 300:933–944PubMedCrossRef Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults. JAMA 300:933–944PubMedCrossRef
5.
go back to reference Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297PubMedCrossRef Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297PubMedCrossRef
6.
go back to reference Van den Berghe G (2008) Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia 51:911–915PubMedCrossRef Van den Berghe G (2008) Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia 51:911–915PubMedCrossRef
7.
go back to reference Okabayashi T, Hnazaki K, Nishimori I et al (2008) Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 53:1405–1410PubMedCrossRef Okabayashi T, Hnazaki K, Nishimori I et al (2008) Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. Dig Dis Sci 53:1405–1410PubMedCrossRef
8.
go back to reference Okabayashi T, Nishimori I, Yamashita K et al (2009) Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 73:47–53PubMedCrossRef Okabayashi T, Nishimori I, Yamashita K et al (2009) Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 73:47–53PubMedCrossRef
9.
go back to reference Harris JA, Benedict FG (1918) A biometric study of human basal metabolism. Proc Natl Acad Sci USA 4:370–373PubMedCrossRef Harris JA, Benedict FG (1918) A biometric study of human basal metabolism. Proc Natl Acad Sci USA 4:370–373PubMedCrossRef
10.
go back to reference Yamashita K, Okabayashi T, Yokoyama T et al (2008) The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 106:160–163PubMedCrossRef Yamashita K, Okabayashi T, Yokoyama T et al (2008) The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 106:160–163PubMedCrossRef
11.
go back to reference Yamashita K, Okabayashi T, Yokoyama T et al (2009) Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand 53:66–71PubMedCrossRef Yamashita K, Okabayashi T, Yokoyama T et al (2009) Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesthesiol Scand 53:66–71PubMedCrossRef
12.
go back to reference Subramaniam B, Panzica PJ, Novack V et al (2009) Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology 110:970–977PubMedCrossRef Subramaniam B, Panzica PJ, Novack V et al (2009) Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology 110:970–977PubMedCrossRef
13.
go back to reference Feringa HH, Vidakovic R, Karagiannis SE et al (2008) Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med 25:314–319PubMedCrossRef Feringa HH, Vidakovic R, Karagiannis SE et al (2008) Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabet Med 25:314–319PubMedCrossRef
14.
go back to reference Okabayashi T, Nishimori I, Maeda H et al (2009) Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 32:1425–1427PubMedCrossRef Okabayashi T, Nishimori I, Maeda H et al (2009) Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 32:1425–1427PubMedCrossRef
15.
go back to reference Okabayashi T, Nishimori I, Yamashita K et al (2010) Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas. Amino Acids 38:901–907PubMedCrossRef Okabayashi T, Nishimori I, Yamashita K et al (2010) Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas. Amino Acids 38:901–907PubMedCrossRef
16.
go back to reference Alfonso A, Koops MK, Mong DP et al (2006) Glycemic control with regular versus lispro insulin sliding scales in hospitalized type 2 diabetics. J Diabetes Complicat 20:153–157PubMedCrossRef Alfonso A, Koops MK, Mong DP et al (2006) Glycemic control with regular versus lispro insulin sliding scales in hospitalized type 2 diabetics. J Diabetes Complicat 20:153–157PubMedCrossRef
17.
go back to reference Hanazaki K, Nose Y, Brunicardi FC (2001) Artificial endocrine pancreas. J Am Coll Surg 193:310–322PubMedCrossRef Hanazaki K, Nose Y, Brunicardi FC (2001) Artificial endocrine pancreas. J Am Coll Surg 193:310–322PubMedCrossRef
18.
go back to reference Okabayashi T, Maeda H, Sun ZL et al (2009) Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection. World J Gastroenterol 15:4116–4121PubMedCrossRef Okabayashi T, Maeda H, Sun ZL et al (2009) Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection. World J Gastroenterol 15:4116–4121PubMedCrossRef
19.
go back to reference Hanazaki K, Maeda H, Okabayashi T (2010) Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 40:1–7PubMedCrossRef Hanazaki K, Maeda H, Okabayashi T (2010) Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 40:1–7PubMedCrossRef
20.
go back to reference Zaret KS, Grompe M (2008) Generation and regeneration of cells of the liver and pancreas. Science 322:1490–1494PubMedCrossRef Zaret KS, Grompe M (2008) Generation and regeneration of cells of the liver and pancreas. Science 322:1490–1494PubMedCrossRef
21.
go back to reference Rodrigues MA, Gomes DA, Andrade VA et al (2008) Insulin induces calcium signals in the nucleus of rat hepatocytes. Hepatology 48:1621–1631PubMedCrossRef Rodrigues MA, Gomes DA, Andrade VA et al (2008) Insulin induces calcium signals in the nucleus of rat hepatocytes. Hepatology 48:1621–1631PubMedCrossRef
22.
go back to reference Nishimura T, Yoshida Y, Watanabe F et al (1986) Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver. Hepatology 6:701–707PubMedCrossRef Nishimura T, Yoshida Y, Watanabe F et al (1986) Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver. Hepatology 6:701–707PubMedCrossRef
23.
go back to reference Klein D, Schubert T, Horch RE et al (2004) Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 240:340–349PubMedCrossRef Klein D, Schubert T, Horch RE et al (2004) Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 240:340–349PubMedCrossRef
24.
go back to reference Bucher ML, Swaffield MN (1975) Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 72:1157–1160PubMedCrossRef Bucher ML, Swaffield MN (1975) Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 72:1157–1160PubMedCrossRef
25.
go back to reference Marchesini G, Marzocchi R, Noia M et al (2005) Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 135:1596S–1601SPubMed Marchesini G, Marzocchi R, Noia M et al (2005) Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 135:1596S–1601SPubMed
26.
go back to reference Fan ST, Lo CM, Lai EC et al (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547–1552PubMedCrossRef Fan ST, Lo CM, Lai EC et al (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547–1552PubMedCrossRef
27.
go back to reference Maeda H, Okabayashi T, Nishimori I et al (2010) Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 199:8–13PubMedCrossRef Maeda H, Okabayashi T, Nishimori I et al (2010) Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 199:8–13PubMedCrossRef
28.
go back to reference Hanazaki K, Maeda H, Okabayashi T (2009) Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 15:4122–4125PubMedCrossRef Hanazaki K, Maeda H, Okabayashi T (2009) Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 15:4122–4125PubMedCrossRef
29.
go back to reference Sugiyama Y, Ishizaki Y, Imamura H et al (2010) Effects of intermittent Pringle’s manoeuvre on cirrhotic compared with normal liver. Br J Surg 97:1062–1069PubMedCrossRef Sugiyama Y, Ishizaki Y, Imamura H et al (2010) Effects of intermittent Pringle’s manoeuvre on cirrhotic compared with normal liver. Br J Surg 97:1062–1069PubMedCrossRef
Metadata
Title
Effect of Perioperative Intensive Insulin Therapy for Liver Dysfunction After Hepatic Resection
Authors
Takehiro Okabayashi
Kengo Ichikawa
Tsutomu Namikawa
Takeki Sugimoto
Michiya Kobayashi
Kazuhiro Hanazaki
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 12/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1299-9

Other articles of this Issue 12/2011

World Journal of Surgery 12/2011 Go to the issue